Clinical trials often depend on patient-reported data to determine whether a participant can move forward in the study. When that data lives in one system and randomization decisions happen in another, sites may have to wait for updates or manually check calculations, adding friction at critical moments.
When eCOA and IRT operate together on a single platform, those decisions can happen in real time, with built-in, automated gates and triggers that guide sites through screening and randomization with greater clarity and confidence.
This case study explores how a biopharmaceutical sponsor used the Suvoda Platform with unified eCOA and IRT to streamline screening and randomization in a global dermatology study.
Download the case study to see how unified technology helped:
- Reduce site burden during screening and randomization
- Eliminate reconciliation between separate systems
- Enable real-time gating based on patient-reported outcomes